Literature DB >> 26955438

Clinicopathological comparisons of open vein harvesting and endoscopic vein harvesting in coronary artery bypass grafting patients in Mashhad.

Ahmad Amouzeshi1, Mohamad Abbassi Teshnisi2, Nahid Zirak3, Alireza Sepehri Shamloo4, Hamid Hoseinikhah5, Behzad Alizadeh6, Aliasghar Moeinipour7.   

Abstract

INTRODUCTION: Harvesting of the greater saphenous vein is almost an inevitable part of coronary artery bypass grafting (CABG) operations, and it is done by two main techniques, i.e., conventional or open vein harvesting (OVH) and the minimally-invasive endoscopic vein harvesting (EVH). This study aimed to compare these two techniques in off-pump CABG procedures with respect to clinical and pathological outcomes.
METHODS: This cohort study was conducted on CABG candidates during a one-year period from October 2013 through September 2014 in the Department of Cardiac Surgery at Mashhad University of Medical Sciences. Eighty-seven patients voluntarily underwent EVH, and another 86 patients matched for age, gender, and other cardiovascular risk factors were selected for OVH. They were followed up for six weeks, and the main outcome measures were infections of the wound, pain, duration of hospital stay, and the costs of hospitalization. Paired sample t-test, independent t-test, or their non-parametric equivalents and the chi-squared test were used by SPSS version 17.0 for data analysis.
RESULTS: The mean duration of time for vein harvesting was shorter in the EVH group (p < 0.001), and the pain score was lower (p = 0.04). No infections occurred at the site of the wound. The length of hospital stay was not significantly different for the two groups (OVH versus EVH: 8.5 ± 3.3 versus 8.4 ± 3.2 days; p-value: 0.08). Hospitalization costs were significantly higher in the EVH group (OVH versus EVH: 5.8 ± 4.7 versus 7.3 ± 2.0 million Tomman; p-value: 0.008), yet no difference was diagnosed with respect to endothelial damage in the vein grafts harvested by the EVH and OVH techniques.
CONCLUSION: EVH is considered as a minimally invasive and safe vein harvesting technique in our Center, and it can reduce the harvesting time and post-operative pain. In addition, its efficiency was similar to that of OVH.

Entities:  

Keywords:  clinical outcome; coronary artery bypass grafting; endoscopic vein harvesting; graft patency; open vein harvesting; pathological outcome

Year:  2016        PMID: 26955438      PMCID: PMC4768916          DOI: 10.19082/1693

Source DB:  PubMed          Journal:  Electron Physician        ISSN: 2008-5842


1. Introduction

The greater saphenous vein (GSV) remains the most commonly harvested conduit for revascularization in coronary artery bypass grafting (CABG) (1, 2). The conventional technique for this procedure has long been open vein harvesting (OVH). Several studies have reported that the OVH technique results in post-operative pain, delayed healing, and prolonged hospital stay (3–5). Therefore, in the past decade, a minimally invasive technique has been developed to reduce the surgical trauma associated with OVH and improve patients’ satisfaction without disturbing the post-surgical outcomes (3–5). There is strong evidence to suggest that the endoscopic vein harvesting (EVH) technique can reduce post-operative infections, pain, mobility restriction, and the duration of hospital stays (6). In preliminary studies, no significant differences in graft patency were observed between the OVH and EVH techniques within six months of the procedures (7). However, in recent studies, it has been suggested that EVH may be accompanied by reduced graft patency (6). From the histological perspective, EVH has been proven to be very similar to the OVH technique; yet certain studies focusing on changes in the endothelial cellular surface are inconsistent with these findings. In a recent study, EVH was associated with a higher rate of venous graft failure and higher rates of mortality, myocardial infarction, and the need for revascularization during the first year after the surgery (3). Since post-op angiographic studies are not routinely performed, we decided to perform this study on elective, off-pump CABG candidates who made their own decisions to undergo the techniques. The aim of this study was to compare the clinical and pathological outcomes of OVH and EVH in patients who underwent the coronary artery bypass grafting procedure. In addition to the clinical and pathological outcomes, we compared the mean fees for the hospital stays for the EVH and OVH groups.

2. Material and Methods

2.1. Study setting

In this cohort study performed from October 2013 through September 2014, all patients scheduled for off-pump CABG in the Cardiac Surgery Ward of Imam Reza Medical were enrolled. Those undergoing CABG for the first time entered either the OVH group (86 cases) or EVH group (87 cases) based on their own decision-making. Patients were included in this study if they were more than 18 years old and scheduled for an elective off-pump CABG for the first time. Patients who also were also candidates for heart-valve surgery, had leg or other ulcers, had active bacterial infections, had simultaneous EVH and OVH, and those who died during surgery were excluded from the study. All operations were performed by a well-experienced surgeon in a single, well-equipped center. The aim of surgery was to obtain complete revascularization by using the graft obtained from the great saphenous vein or the left internal mammalian artery. The anesthesia protocol was similar for all subjects.

2.2. Endoscopic vein harvesting technique

EVH was performed in group A using the Vaso-View system (Open carbon dioxide (CO2), Sorin Group Co). Dissection and visualization are possible in this exclusive technique in the presence of CO2. Provision of cases was the same with peripheral readiness in order to open harvesting. Openings were performed in the center on the upper and/or the bottom part of the knee through a small cut of 1.5 to 2.5 cm, in accordance with the required length of selected vein; cutting was not done in the region of the knee flexor. Harvesting was conducted primarily to the groin region in order to get the enough vessel length (24). Bipolar cauterizing scissors were used for splitting the lateral branches when the peripheral vein was removed. A small cut was made close to the origin on the basis of endoscopic vision on saphenous vein to seal, freeze, and split the vessel for removal and preparation. After that, the lateral branches were closed and 7-0 monofilament prolene sutures were used, if required. Endoscopic dissection was done beneath the leg away from the center when an extra length of vessel was required. Typically, two or three pieces of the saphenous vein can be removed with each measuring about 15 cm (24). The lesions of the leg were examined closely for any bleeding, and they were kept open to reverse the effects of heparin. The removed regions were rubbed lightly in order to detect any bleeding or clotting, and, then, absorbable subcutaneous and subcuticular sutures were used to close the area. The wound was bandaged with elastic ACE™ wrapfor 48 hours without draining.

2.3. Open operative Technique of vein harvesting (OVH)

Group B patients underwent conventional open vein harvesting. Long cutting were carried out in the saphenous vein area depending on the required number and length of vein grafts (24). When the vessel was visible, lateral branches were closed or clipped on both the case side and the graft side. Bipolar cauterizing scissors was used to divide the vein branches. The open leg wound was checked for hemostasis (24). The incisions were closed in layers by absorbable sutures and then ended by a subcuticular closure. Finally, the wound was wrapped with cotton gauze, and an ACE™ wrap was applied to the entire leg for 48 hours. The open leg wound is then checked for hemostasis and irrigated with saline solution.

2.4. Studied variables

Demographic data, such as age, gender, body mass index (BMI), positive medical history of chronic obstructive pulmonary disease (COPD), asthma, transient ischemic attack (TIA), and diabetes were mentioned in each patient’s history. Then, echocardiographic reports for ventricular ejection fraction (EF %), baseline serum creatinine (mg/dL), and hematocrit levels (%) were recorded for all patients. Then we recorded the circumference (cm) of the ankle of the target leg for harvesting leg, and pre-operative intra-aortic balloon pump (IABP) use was recorded. During the surgery, the mean duration (min), the mean blood products required during the operation, and the mean number of grafts performed were entered on the patients’ records for both groups. Surgical outcomes were the length of the incision on the leg (cm), the mean harvesting time (min), and the length of the harvested vein (cm). During the surgery, a specimen of the harvested vein was sent for pathological examination. Patients were followed up on the second day of their stay in the post-surgical intensive care unit (ICU) and on the last day of their stay in the post-surgical ward. Also, all patients were monitored for six weeks. ICU and ward observed clinical outcomes were as follows: the circumference (cm) of the ankle of the harvesting leg, pain score (by visual analog scale), serum albumin level (mg/dL), serum creatinine level (mg/dL), positive troponin levels (n), number of transfusion blood pack cells, cardiac arrhythmia, cerebrovascular accident (CVA), IABP use, re-operation rate, and death rate. Mean hospital stay and the fees for the hospital stays also were compared for the two groups. All patients were monitored for six weeks for the circumference of the ankle of the leg of harvested vein, the pain score, and the rate of wound infections.

2.5. Research ethics

The study protocol was approved by the Ethics Committee of Mashhad University of Medical Sciences and described to all patients. An informed consent was taken from each participant prior to entering the study.

2.6. Statistical analyses

SPSS version 17.0 (SPSS, Inc., Chicago, Illinois, United States of America) software was used to analyze the data. The paired sample t-test, the independent t-test, their non-parametric equivalents, and the chi-squared test were used as appropriate. The significance level was set at p < 0.05.

3. Results

3.1. General findings

In total, 173 patients were studied. The demographic characteristics of the two groups as they entered the study are provided in Table 1. Para clinic studies, including ventricular ejection fraction (EF %) (OVH vs. EVH: 44.3 ± 11.6 vs. 50.5 ± 12.1; p = 0.092), serum creatinine (mg/dL) (OVH vs. EVH: 1.1 ± 0.7 vs. 1.1 ± 0.4; p = 0.625), and hematocrit levels (%) (OVH vs. EVH: 40.5 4.9 vs. 38.1 ± 4.8; p = 0.312) on the pre-op day showed no significant difference between the two groups. Moreover, the two groups of OVH and EVH were similar regarding the mean duration of surgery (min) (OVH vs. EVH: 263.2 ± 66.3 vs. 256.8 ± 60.4; p = 0.412) and the mean blood products required during the operation (n) (OVH vs. EVH: 1.0 ± 1.3 vs. 1.0 ± 1.2; p = 0.734). Among the 173 patients who underwent CABG, 584 grafts were performed with a mean number of 3.37 grafts per patient, indicating no meaningful difference between the OVH and EVH groups (OVH vs. EVH: 3.2 ± 0.7 vs. 3.4 ± 0.6; p = 0.061)
Table 1

Demographic characteristics of the OVH and EVH groups at study entrance

VariableOVH* (n=86)EVH** (n=87)p-value
Age (yrs)59.98 ± 10.4959.36 ± 8.2070.665
Body Mass IndexNormal43.5%40.5%0.969
Overweight40%41.7%
Obese15.3%15.5%
SexMale62.4%65.5%0.666
Female37.6%34.5%
COPD1.2%1.1%1.00
Asthma2.3%3.4%1.00
Smoking33.7%31%0.706
Transient Ischemic Attack16.3%4.7%0.023
Diabetes37.2%43%0.437
Pre-operation IABP*** use4.7%2.3%0.682
The ankle circumference of the harvesting leg (cm)23.66 ± 2.5823.60 ± 1.820.841

OVH: Open Vein Harvesting,

EVH: Endoscopic Vein Harvesting, IABP: Intra-Aortic Balloon Pump

3.2. Comparison of surgical outcomes

The lengths of the incisions in the legs of the EVH group were significantly less than those in the OVH group, showing a meaningful difference (3.719 ± 3.66 vs. 16.963 ± 45.92 cm, p<0.001). The mean harvesting time also was significantly less in the EVH group than in the OVH group (16.518 ± 36.55 vs. 23.680 ±56.57 min, p < 0.001). Accordingly, the length of the harvested vein in the EVH group was less than that in the OVH group (14.440 ± 35.59 vs. 15.932 ± 44.47, p = 0.009). The most common locations for vein harvesting in both groups were above and below the knee (86.46% vs. 86.40%). However, in the OVH group, the most commonly used location was below the knee, whereas it was above the knee in the EVH group, showing a meaningful difference (p = 0.01).

3.3. Comparison of post-op complications in the ICU and during hospitalization in the cardiac surgery ward

In the ICU, no significant difference was found between the EVH and OVH groups considering the studied variables in their post-op ICU stay (Table 2). During hospitalization in the cardiac surgery ward, no significant difference was found between the two groups considering the studied variables in post-op ward stay (Table 3). The only difference between the two groups at the end of hospital stay was the hospital fees (Table 3).
Table 2

Clinical outcome of the OVH and EVH groups in post-surgery intensive care units (ICU)

VariableOVH (n=86)EVH (n=87)p-value
The ankle circumference of the harvesting leg, cm (Mean ± SD)24.0 ± 2.524.1 ± 2.00.319
Pain score, (Mean ± SD)2.0 ± 1.61.6 ± 1.40.058
Serum Albumin level, mg/dL (Mean ± SD)3.2 ± 0.43.2 ± 0.30.514
Positive Troponin, n (%)00-
Serum Creatinine level, mg/dL (Mean ± SD)1.1 ± 0.71.1 ± 0.50.691
Blood Pack cell infusion, n (%)39 (45.3%)33 (37.9%)0.734
Cardiac arrhythmia
Premature ventricular contractions (PVCs), n (%)11 (12.7%)5 (5.7%)0.115
Ventricular tachycardia (VT), n (%)1 (1.1%)00.494
Atrial Fibrillation (AF), n (%)2 (2.3%)1 (1.1%)0.621
Cerebrovascular accident (CVA), n (%)00-
Intra-aortic Balloon Pump (IABP) use, n (%)9 (10.4%)8 (8.6%)0.803
Re-operation3 (3.5%)5 (5.7%)0.720
Death, n (%)3 (3.5%)2 (2.2%)0.619

OVH: Open Vein Harvesting, EVH: Endoscopic Vein Harvesting

Table 3

Clinical outcome of the OVH and EVH groups in post-surgery hospital stay in cardiac surgery ward

VariableOVH (n=83)EVH (n=85)p-value
The ankle circumference of the harvesting leg, cm (Mean ± SD)22.7 ± 1.723.2 ± 1.60.077
Pain score, (Mean ± SD)1.6 ± 1.31.2 ± 1.10.003
Serum Albumin level, mg/dL (Mean ± SD)3.2 ± 0.43.2 ± 0.30.514
Positive Troponin, n (%)00-
Serum Creatinine level, mg/dL (Mean ± SD)1.7 ± 0.81.1 ± 0.80.922
Blood Pack cell infusion, n (%)000
Cardiac arrhythmia
Premature ventricular contractions (PVCs), n (%)1 (1.2%)00.497
Ventricular tachycardia (VT), n (%)00-
Atrial Fibrillation (AF), n (%)1 (1.2%)00.497
Cerebrovascular accident (CVA), n (%)1 (1.2%)00.497
Intra-aortic Balloon Pump (IABP) use, n (%)00-
Re-operation00-
Death, n (%)00-
Hospital Stay, day (Mean ± SD)8.5 ± 3.38.4 ± 3.20.088
Hospital Stay Fee, Milion Tomman (Mean ± SD)5.8 ± 4.77.3 ± 2.00.008

OVH: Open Vein Harvesting, EVH: Endoscopic Vein Harvesting

3.4. Six-week follow-up outcomes

In the sixth post-op week, the circumference (cm) of the ankle of the leg of harvested vein (OVH vs. EVH: 23.7 ± 1.5 vs. 23.4 ± 1.4; p = 0.309) showed no meaningful difference between the two groups. Pain score was significantly less in the EVH group than in the OVH group (OVH vs. EVH: 1.3 ± 0.8 vs. 0.9 ± 1.08; p = 0.02). Also, no cases of wound infection were observed in either group.

3.5. Pathological outcome

The vein grafts taken in the two groups showed no meaningful difference regarding their pathologic status based on endothelia injury (OVH vs. EVH: 2.3% vs. 0.0%; p = 0.241) and intimal fibrosis (OVH vs. EVH: 8.1% vs. 2.3%; p = 0.091).

4. Discussion

Abundant evidence has emerged in the recent years emphasizing that EVH is accompanied with a lower rate of leg-wound morbidity, better cosmetic results, and improved patient satisfaction (1, 8, 9). Despite all such advantages, there are still certain concerns regarding the potential ability of this technique to damage the endothelial integrity of the vein (10). However, the results of our study showed that EVH did not cause any undesired clinical outcomes and the patients experienced less pain than the OVH group. In this study, the post-op pain score during the 6-week follow-up period in the EVH group was significantly less than the OVH group. In other similar studies that also have used the VAS for pain assessment, patients undergoing EVH rated their experience of pain on a 0–10 scale two points lower throughout the entire post-operative period and were pain-free a few days earlier than the OVH group (5, 11, 12). Patients undergoing EVH due to experiencing less pain had shorter time to mobilization (12, 13). In the study by Cheng et al. (31), the rate of pain (23.1% vs. 6.7%), neuralgia (24.3% vs. 7.1%), and patient satisfaction (49% vs. 75%) were in a better status in the EVH than in the OVH group. One of the other complications of vein harvesting is infection at the site of the incision. Various studies have indicated that the rate of infection in the OVH group varies between 2–25%, resulting in significant clinical complications and additional costs to the healthcare system (3). In a meta-analysis by Athanasiou et al. of eleven RCTs, the EVH technique was associated with a significantly lower rate of infection at the harvesting site than OVH (OR = 0.22, p < 0.00001) (15). In another meta-analysis including 35 studies, the EVH group again had a lower infection rate (p < 0.0001) (16). In another study by Raja et al. in 2013 (3) on 411 CABG patients, the rate of infection at the harvesting site was followed up for four years. It was reported that the EVH technique almost eliminates the probability of infection at this site when compared to the OVH technique (1.13% vs 1.3%, p < 0.001). The reason may be due to the smaller incision and the safe transfer of tissue in this surgical method. Another less important aspect may be due to preserved tissue perfusion and a lower likelihood of creating vital tissue flaps. However, the highlight of the current study was the zero infection rate in the 6-week follow-up period. This lower rate of infection in the EVH technique compared to OVH is of particular value in diabetic and obese patients and those with peripheral arterial diseases in whom EVH is considered the method of choice (17, 18). Irrespective of the harvesting site’s infection rate, which has always been a major concern, complications related to the quality of the harvested vein, which, by closing the graft, can cause serious complications in other organs, is of great importance as well. In the current study the two groups were compared regarding heart, kidney, and cerebral complications during hospitalization, and there were no meaningful differences. Myocardial infarction (MI) is the most important complication, and it is an indicator of the graft’s patency. In this study, similar to others, no difference was seen in the rate of MI in the short-term. In a meta-analysis by Satry et al. in 2013 (16) that included twelve studies and 3,872 patients, no difference was reported in the rate of MI after the operation by either technique (SR risk: 0.87; 95% CI: 0.68–1.11; p = 0.26). One of the other important factors in estimating the safety of a certain technique is investigating the short-, mid- and long-term mortality. Our study showed no difference in mortality during hospitalization and the 6-week follow-up between the two groups. This also was reported in the few meta-analyses performed comparing EVH and OVH. Yet, more studies are required regarding this issue in order to obtain more precise results, especially in short- and mid-term follow ups. Another important aspect of the current study is the therapeutic costs for which higher costs were achieved in the EVH group compared to OVH. It seems that this is mostly related to the cost of the technique itself. According to the few studies that have investigated this issue, it has been observed that the shorter time to ambulation and the lower rate of leg wound morbidity result in shortened hospital stay and lower medical costs in the EVH group (3). However, the two we studied showed no meaningful difference regarding the lengths of their hospital stays. Despite the increasing recognition of the benefits of the EVH technique, the quality of the harvested vein is still a major concern, because endothelial injury affects the graft opening following CABG. Studies in this respect have controversial results; Hussaini et al. reported no difference in the structural and functional viability of the saphenous vein endothelium between the EVH and OVH groups, yet they stated that the vasomotor function may decrease (19). Wang et al. also published similar results (20). Andreasen’s study in 2015 showed that over the past 6.3 years, the majority of vein graft failures were significantly detected by EVH rather than OVH without any differences in long-term clinical outcomes (21). Angiographic follow-up results had no difference with clinical outcomes in cases with open versus endoscopic harvesting for coronary bypass surgery (23). The EVH is an ordinary technique to train for removing vein conduit in CABG (24). These findings led to increases in endoscopic vein harvesting (EVH). Reduction in wound complications, satisfaction of recovery, shorter durations of admission, and reduced post-operative pain at the opening area after EVH have been reported when EVH and OVH were compared (24). The 2014 Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Guidelines on Myocardial Revascularization addressed the methods of conduit harvest and issued a Class IIa Level A recommendation for EVH. This recommendation, which represents the first formal recommendation for EVH by ESC/EACTS, was based on data from meta-analyses as well as randomized trials, noting that nearly all studies documented reductions in wound infection and impaired healing, and the Guidelines also asserted that the most recent data do not demonstrate inferior clinical outcomes with EVH. The recommendation based on 2014 ESC/EACTS Guidelines about EVH is “Endoscopic vein harvesting should be considered to reduce the incidence of leg wound complications” (25). Moreover, in this study the vein grafts taken in the two groups showed no meaningful difference regarding their pathological findings (p = 0.241). This study had two main limitations. First, we could not do a post-operative control angiography or CT-angiography for evaluating the grafts patency, because there was no evidence of graft failure in our studied population. So, we were not able to publish the comparison of grafts patency between two groups of EVH and OVH. The second limitation was the short time of the follow-up. We recommend to the other researchers to compare the clinical outcomes of EVH and OVH over longer follow-up periods.

5. Conclusions

The findings of the current study revealed that the harvesting time is generally shorter in the EVH technique in contrast to several other studies. This discrepancy in the results may be due to the experience of the technicians and the equipment used for this purpose. A shorter harvesting time results in a shorter period of post-op care regarding leg-wound morbidity. It seems that we have once again illustrated an important link between minimally-invasive great saphenous vein harvesting and improved tissue healing when compared to conventional open surgery. However, additional research is required to investigate the cosmetic outcomes, hospital costs, and cost-efficiency further; more importantly, long-term graft patency should be investigated in the EVH technique. Taking into consideration the large number of CABG procedures performed in our region using the EVH technique, its training course should be further valued and emphasized to improve the quality of vein grafts besides causing minimal injury to the surrounding tissue.
  23 in total

1.  Initial experience with endoscopic saphenous vein harvesting for coronary artery bypass grafting in Chinese patients.

Authors:  Huishan Wang; Haibo Wu; Hui Jiang; Zengwei Wang; Evginij Potapov; Alexander Stepanenko
Journal:  Heart Surg Forum       Date:  2011-10       Impact factor: 0.676

2.  Saphenous vein grafts: to use or not to use?

Authors:  Shahzad Gull Raja; Zulfiqar Haider; Mukhtar Ahmad; Haider Zaman
Journal:  Heart Lung Circ       Date:  2004-12       Impact factor: 2.975

3.  Is minimally invasive harvesting of the great saphenous vein for coronary artery bypass surgery a cost-effective technique?

Authors:  Christopher Rao; Omer Aziz; Samer Deeba; Andre Chow; Catherine Jones; Zhifang Ni; Leonidas Papastavrou; Shamim Rahman; Ara Darzi; Thanos Athanasiou
Journal:  J Thorac Cardiovasc Surg       Date:  2008-04       Impact factor: 5.209

4.  A prospective randomized trial of endoscopic versus conventional harvesting of the saphenous vein in coronary artery bypass surgery.

Authors:  Bob Kiaii; Byung C Moon; David Massel; Yves Langlois; Thomas W Austin; Andrea Willoughby; C Guiraudon; Craig R Howard; L Ray Guo
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

5.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Philippe Kolh; Stephan Windecker; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Çetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Miguel Sousa Uva; Stephan Achenbach; John Pepper; Anelechi Anyanwu; Lina Badimon; Johann Bauersachs; Andreas Baumbach; Farzin Beygui; Nikolaos Bonaros; Marco De Carlo; Christi Deaton; Dobromir Dobrev; Joel Dunning; Eric Eeckhout; Stephan Gielen; David Hasdai; Paulus Kirchhof; Heyman Luckraz; Heiko Mahrholdt; Gilles Montalescot; Domenico Paparella; Ardawan J Rastan; Marcelo Sanmartin; Paul Sergeant; Sigmund Silber; Juan Tamargo; Jurrien ten Berg; Holger Thiele; Robert-Jan van Geuns; Hans-Otto Wagner; Sven Wassmann; Olaf Wendler; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2014-08-29       Impact factor: 4.191

6.  Routine minimal invasive vein harvesting reduces postoperative morbidity in cardiac bypass procedures. Clinical report of 1400 patients.

Authors:  R Coppoolse; W Rees; R Krech; M Hufnagel; K Seufert; H Warnecke
Journal:  Eur J Cardiothorac Surg       Date:  1999-11       Impact factor: 4.191

Review 7.  Endoscopic vein harvesting: technique, outcomes, concerns & controversies.

Authors:  Shahzad G Raja; Zubair Sarang
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

8.  In-hospital outcomes of off-pump multivessel total arterial and conventional coronary artery bypass grafting: single surgeon, single center experience.

Authors:  Shahzad G Raja; Hajira Siddiqui; Charles D Ilsley; Mohamed Amrani
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

9.  Evaluation of endoscopic vein extraction on structural and functional viability of saphenous vein endothelium.

Authors:  Bader E Hussaini; Xiu-Gui Lu; J Alan Wolfe; Hemant S Thatte
Journal:  J Cardiothorac Surg       Date:  2011-06-10       Impact factor: 1.637

10.  Early Outcomes of Endoscopic Vein Harvesting during the Initial Learning Period.

Authors:  Do Yeon Kim; Hyun Song; Hwan Wook Kim; Gyun Hyun Jo; Joonkyu Kang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.